|
|
| Model Number |
EEA21 |
| Medical Device Problem Code |
Failure to Fire (2610)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
09/24/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
D10 concomitant product: gia10038s, gia10038s gia100-3.8 sgl usereloadstap, (lot # p3c0375s).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
According to the reporter, the patient had t3b (tumor has spread to the seminal vesicles) gastric cancer and underwent radical surgery for gastric cancer under open surgery.When detaching the duodenum, the linear open stapler was used, the staples burst out, the staples were not formed well, and the anastomosis was bleeding.The staple line opened up.Finally, it was sutured manually.When the small intestine and esophagus were subsequently anastomosed, the open circular stapler was used, but it could not be fired.After replacing it with a new circular stapler, the operation was completed.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic conducted an investigation based upon all information received.The device was available for evaluation.The evaluation found no potentially contributing factors, and the sample met all related specifications.It was reported that the instrument did not fire.The reported issue could not be confirmed.The most likely cause could not be identified because no related problem was detected with the device.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|
|
|